Showing results (3831-3840 of 8,680) with videos related to

Sort By:
Pageof 868
Bioorganic Chemistry|December 27, 2024
Synthesis of novel spiroisoxazolidino hybrids of alantolactone and isoalantolactone via 1,3 dipolar nitrone cycloaddition and its antimicrobial EvaluationAliya Tabassum, Diksha Kumari, Harshad B Bhore, et al.
Bioorganic Chemistry|December 12, 2024
A GH1 β-glucosidase from the Fervidobacterium pennivorans DSM9078 showed extraordinary thermostability and distinctive ability in the efficient transformation of ginsenosidesKailu Zhou, Yangyang Zhang, Minghao Xu, et al.
Bioorganic Chemistry|January 3, 2025
A self-assembled fluorescent nanoprobe recognized by FA1 site for specifically selecting HSA: Its applications in hemin detection, cell imaging and fluorescent tracing drug deliveryBo-Wen Ding, Ruo-Xi Sang, Xiao-Yu Li, et al.
Bioorganic Chemistry|January 7, 2025
Modular cascade with engineered HpaB for efficient synthesis of hydroxytyrosolWen-Kai Liu, Xiu-Xin Ren, Lian Xu, et al.
Bioorganic Chemistry|January 5, 2025
Exploring the therapeutic potential of acridines: Synthesis, structure, and biological applicationsDiego Santa Clara Marques, Lisandra da Silva Lima, Josué Filipe de Oliveira Moraes Miranda, et al.
Bioorganic Chemistry|December 10, 2024
An overview of phenylsulfonylfuroxan-based nitric oxide donors for cancer treatmentChao Gao, Xingyu Li, Tong Liu, et al.
Bioorganic Chemistry|December 5, 2024
Advances in the structural modification of Alzheimer's disease drug - Huperzine AXiaoxin Zhu, Jin-Bu Xu, Feng Gao, et al.
Bioorganic Chemistry|December 6, 2024
X-ray induced in-situ ferroptosis through the Fenton reaction of iron supplements for the cancer therapyWang Qian, Caiju Zhang, Li He, et al.
Bioorganic Chemistry|December 7, 2024
Podocarpane and cleistanthane diterpenoids from Strophioblachia glandulosa: structural elucidation, anti-hypertrophy activity and network pharmacologyXue-Wen Wu, Yong-Xiang Huang, Chao-Jun Li, et al.
Bioorganic Chemistry|December 7, 2024
Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2/AKT and apoptosis inducers against hepatocellular carcinoma with docking simulationMoustafa S Abusaif, Ahmed Ragab, Eman A Fayed, et al.
Pageof 868